510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K951639Substantially Equivalent

Complement Activation Eia Test System (Cae)

Incstar Corp., Stillwater MN / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K951639 is the FDA 510(k) clearance record for COMPLEMENT ACTIVATION EIA TEST SYSTEM (CAE), a class II device, cleared for Incstar Corp. on under FDA product code DAE (Complement C9, Antigen, Antiserum, Control). FDA records list 58 510(k) clearances for Incstar Corp., from to . As of , FDA records show no recalls naming K951639.

Clearance record

Decision date
Received
(186 days to decision)
Product code
DAE Complement C9, Antigen, Antiserum, Control
Regulation
21 CFR 866.5240
Device class
Class II
Review panel
Immunology
Applicant
Incstar Corp. 1990 Insustrial Blvd., Stillwater MN
510(k) summary
Summary
Third party review
No

Clearances, product code DAE

Trailing 12 months

FDA records hold no clearances under product code DAE in the trailing twelve months.

FDA records show no clearances under product code DAE in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DAE, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260